Cargando…
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
Although vesicular stomatitis virus (VSV) neurovirulence and pathogenicity in rodents have been well studied, little is known about VSV pathogenicity in non-human primates. To address this question, we measured VSV viremia, shedding, and neurovirulence in macaques. Following intranasal inoculation,...
Autores principales: | Johnson, J. Erik, Nasar, Farooq, Coleman, John W., Price, Roger E., Javadian, Ali, Draper, Kenneth, Lee, Margaret, Reilly, Patricia A., Clarke, David K., Hendry, R. Michael, Udem, Stephen A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865117/ https://www.ncbi.nlm.nih.gov/pubmed/17098273 http://dx.doi.org/10.1016/j.virol.2006.10.026 |
Ejemplares similares
-
Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
por: Mire, Chad E., et al.
Publicado: (2012) -
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006) -
In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation
por: Erik Johnson, J., et al.
Publicado: (2009) -
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
por: Fathi, Anahita, et al.
Publicado: (2019) -
Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
por: Woolsey, Courtney, et al.
Publicado: (2018)